Biomarker discovery offers hope for new TB vaccine

(University of Oxford) Researchers have identified new biomarkers for Tuberculosis (TB) which have shown for the first time why immunity from the widely used Bacillus Calmette-Guérin (BCG) vaccine is so variable.